Literature DB >> 14639541

Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia.

Grant S Schulert1, Heather Feltman, Shira D P Rabin, Ciara G Martin, Scott E Battle, Jordi Rello, Alan R Hauser.   

Abstract

Overall, hospital-acquired pneumonia (HAP) caused by Pseudomonas aeruginosa is associated with high attributable mortality. Although the intrinsic virulence of P. aeruginosa undoubtedly contributes to this phenomenon, it is unclear whether all strains share this property or whether only a subpopulation of strains are capable of causing such severe disease. In this study, the virulence of 35 P. aeruginosa isolates obtained from patients with HAP by use of a cytolytic cell-death assay, an apoptosis assay, and a mouse model of pneumonia. The virulence of individual isolates differed significantly from one to another in each of these assays. Increased virulence was associated with the secretion of ExoU, a toxin transported by the P. aeruginosa type III secretion system. Secretion of ExoS or ExoY, 2 other proteins transported by this system, was not consistently associated with increased virulence. Together, these findings suggest that secretion of ExoU is a marker for highly virulent strains of P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14639541     DOI: 10.1086/379372

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  88 in total

1.  Survey of ferroxidase expression and siderophore production in clinical isolates of Pseudomonas aeruginosa.

Authors:  Wilhelmina M Huston; Adam J Potter; Michael P Jennings; Jordi Rello; Alan R Hauser; Alastair G McEwan
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

Review 2.  Modeling the function of bacterial virulence factors in Saccharomyces cerevisiae.

Authors:  Raphael H Valdivia
Journal:  Eukaryot Cell       Date:  2004-08

3.  Role of the membrane localization domain of the Pseudomonas aeruginosa effector protein ExoU in cytotoxicity.

Authors:  Jeff L Veesenmeyer; Heather Howell; Andrei S Halavaty; Sebastian Ahrens; Wayne F Anderson; Alan R Hauser
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

Review 4.  From GFP to β-lactamase: advancing intact cell imaging for toxins and effectors.

Authors:  Madison Zuverink; Joseph T Barbieri
Journal:  Pathog Dis       Date:  2015-10-22       Impact factor: 3.166

5.  Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion.

Authors:  Daniel Aiello; John D Williams; Helena Majgier-Baranowska; Ishan Patel; Norton P Peet; Jin Huang; Stephen Lory; Terry L Bowlin; Donald T Moir
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

6.  A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells.

Authors:  Shira D P Rabin; Jeffrey L Veesenmeyer; Kathryn T Bieging; Alan R Hauser
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  Presence of the exoU gene of Pseudomonas aeruginosa is correlated with cytotoxicity in MDCK cells but not with colonization in BALB/c mice.

Authors:  Hsi-Hsun Lin; Shiao-ping Huang; Hsiu-Chen Teng; Dar-Der Ji; Yao-Shen Chen; Ya-Lei Chen
Journal:  J Clin Microbiol       Date:  2006-10-18       Impact factor: 5.948

8.  In vitro assays to monitor the activity of Pseudomonas aeruginosa Type III secreted proteins.

Authors:  Stephanie L Rolsma; Dara W Frank
Journal:  Methods Mol Biol       Date:  2014

9.  Pseudomonas aeruginosa uses T3SS to inhibit diabetic wound healing.

Authors:  Josef Goldufsky; Stephen J Wood; Vijayakumar Jayaraman; Omar Majdobeh; Lin Chen; Shanshan Qin; Chunxiang Zhang; Luisa A DiPietro; Sasha H Shafikhani
Journal:  Wound Repair Regen       Date:  2015-07-27       Impact factor: 3.617

10.  Pseudomonas aeruginosa induces localized immunosuppression during pneumonia.

Authors:  Maureen H Diaz; Ciara M Shaver; John D King; Srinidhi Musunuri; Jeffrey A Kazzaz; Alan R Hauser
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.